Ribosomal protein L15 pseudogene 22 (RPL15P22)

Ribosomal protein L15 pseudogene 22 is a processed pseudogene in the human genome, corresponding to the ribosomal protein L15 gene (RPL15)[2][3]. Pseudogenes are non-functional genomic DNA sequences similar to normal genes but typically lack the ability to encode a functional protein. RPL15P22, as indicated by its name, does not produce a functional protein and thus has no established biological functions, disease associations, or role as a therapeutic target. It is not considered a genuine drug target in pharmacology or drug discovery and is mainly of interest in genomic annotation or studies of pseudogene evolution rather than biomedical application[2][3][6]. - RPL15, the parental gene, is a protein-coding gene essential for ribosome structure and function, but RPL15P22 itself is a pseudogene and does not contribute to ribosome function[5][1]. - No approved drugs or biomarkers are associated with RPL15P22. Summary of key points: - RPL15P22 is not a therapeutic target and does not encode a functional protein. - It is classified scientifically as a pseudogene and not a functional molecular target or receptor. - The entry is technically correct, but it is not relevant as a drug target—thus, is_incorrect: true in the context of therapeutic target queries[2][3].

Other names

RPL15_10_1742